Stay cool with the latest edition of "Weekly Update!" We have not one but two STAT investigations - plus, biotech updates, Fauci on the First Opinion podcast, Elmo and friends, and much more! Read now ⬇
STAT
Internet News
Boston, Massachusetts 31,621 followers
Reporting from the frontiers of health and medicine.
About us
Reporting from the frontiers of health and medicine We take you inside the science labs and hospitals, biotech boardrooms and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all. Get access to exclusive content: http://www.statnews.com. Follow us on Twitter @statnews and on Facebook at facebook.com/statnews
- Website
-
http://www.statnews.com
External link for STAT
- Industry
- Internet News
- Company size
- 51-200 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
- Specialties
- news, science news, medicine, health, biotech, pharma, health tech, covid, hospitals, and business
Locations
-
Primary
1 Exchange Pl
Boston, Massachusetts 02109, US
Employees at STAT
Updates
-
Opinion: Genetic testing can help people who may have a rare disease. Until public and private insurance covers the costs of this testing, the federal government should support biotech companies' provision of tests. https://trib.al/ikHfnWe
Sponsored genetic testing programs are under fire, further complicating life for people with rare diseases
https://www.statnews.com
-
In today's health tech news: A closer look at Medicare's plans to cover digital therapeutics, a big HHS revamp, and a key FDA exit. https://trib.al/SEz7eHs
Six questions about Medicare's proposed plan to cover digital therapeutics
https://www.statnews.com
-
Viking Therapeutics plans to move its injectable obesity treatment into a Phase 3 study faster than expected, bringing the biotech closer to joining the highly competitive GLP-1 drug market. https://trib.al/azTkixN
A potential rival for Wegovy and Zepbound enters the fray
-
The insurer UnitedHealth is using its unrivaled physician empire to enrich itself by milking Medicare Advantage. Read Part 1 of this STAT Investigation into Health Care’s Colossus. https://trib.al/XBiKST3
How UnitedHealth harnesses its physician empire to squeeze profits out of patients
https://www.statnews.com
-
A little-known office within HHS is getting a shot in the arm as part of an agency reorganization aimed at better regulating health data and AI. https://trib.al/jpDyGfs
Federal regulation of health data and AI expected to get a boost after HHS revamp
https://www.statnews.com
-
Insurers like UnitedHealth are profiting off of the Medicare Advantage system, and it's causing problems for both doctors and patients. Watch to learn more. https://trib.al/k7idqEk
How insurers use doctors to profit off medical codes
https://www.statnews.com
-
Opinion: There's an overlooked innovation in the FDA's non-approval of MDMA for PTSD — combining a medication and a psychotherapy as a bundled intervention. https://trib.al/nC9MI0Z
Adding psychotherapy to drug therapy works, but the FDA may not be able to handle it
https://www.statnews.com
-
The San Diego-based biotech said Wednesday during an earnings call that it's moving directly to a Phase 3 study of its drug, after getting feedback from regulators, rather than starting a Phase 2B study. https://trib.al/sh3GyWD
Viking accelerates development of obesity drug that could rival Wegovy, Zepbound
https://www.statnews.com
-
We're just 3 months away from the 2024 #STATSummit in Boston! Get one year of STAT free with your purchase of a Summit ticket. Current STAT subscribers save 25% off their pass. Learn more about registering for this two-day event: https://trib.al/odYpIJU
-